• <object id="wyj0v"></object>

    1. <pre id="wyj0v"></pre>
      1. <table id="wyj0v"></table>
        <samp id="wyj0v"><del id="wyj0v"><xmp id="wyj0v"></xmp></del></samp>

        Enoxaparin Sodium
        CAS No.: 679809-58-6 (Low molecular weight heparin)

        Short Description:

        Source: Extracted from porcine intestinal mucosa and degraded by β-elimination method.

        Function and use: By inhibiting coagulation active factor X (FXa) and thrombin (FIIa), heparin pentose structure binds AT-III (antithrombin III), and exerts anticoagulant effect.
        Enoxaparin sodium prevents venous thromboembolic disease (prevention of thrombosis in the veins), especially those associated with orthopaedic or general surgery; treats established deep vein thrombosis, with or without pulmonary embolism, clinical Symptoms are not severe, excluding pulmonary embolism requiring surgery or thrombolytic therapy; treatment of unstable angina pectoris and non-Q-wave myocardial infarction, in combination with aspirin; used in hemodialysis cardiopulmonary bypass to prevent thrombosis; treatment of acute ST segment Elevated myocardial infarction, combined with thrombolytics or concurrently with percutaneous coronary intervention (PCI).

        Enoxaparin?Sodium-Pharmacopoeia?Standard:?BP/EP

        product-description1


        Product Detail

        Product Tags

        Specification

        Enoxaparin Sodium
        Source Intestinal mucosa of pigs
        Quality standard

        USP

        EP

        characters

        Appearance

        /

        white or almost white; hygroscopic powder
        solubility

        /

        freely soluble in water
        identification The spectra exhibit maxima at 231±2nm

        The 13C NMR spectrum obtained is similar to that obtained with the appropriate specific Enoxaparin sodium CRS

        The spectra are similar

        15 -25 % bearing the 1,6-anhydro structure at the reducing end of their chain15%- 25 % of components bearing the 1,6-anhydro structure at the reducing end of their chain

        Anti-factor Xa activity/ anti-factor IIa : 3.3-5.3

        Anti-factor Xa activity/ anti-factor IIa : 3.3-5.3

        Mw : 3800 -5000Da, M≤2000 : 12.0%-20.0%,?????????????????????????????? M≥8000:NMT 18.0%, M2000-8000:68.0%-82.0%

        Mw : 3800 -5000Da, M≤2000 :12.0%-20.0%,

        M2000-8000:68.0%-82.0%

        Meets the requirements for Sodium chemical identification tests

        It complies with the test for sodium
        Appearance of solution /

        clear;NMT: intensity 6

        Specific Absorbance 14.0-20.0 (on the dried basis)

        14.0-20.0 (on the dried basis),determined at 231nm

        pH

        6.2-7.7

        6.2-7.7

        Benzyl alcohol

        ≤ 0.1%

        ≤ 0.1%

        Molar ratio of Sulfate carboxylate ≥ 1.8 ≥ 1.8
        Nitrogen

        1.8 %-2.5 % (on the dried basis)

        1.5 %-2.5 % (on the dried basis)

        Sodium 11.3% -13.5% (on the dried basis)

        11.3% -13.5% (on the dried basis)

        Loss on drying

        ≤ 10.0%

        ≤ 10.0%

        Bacterial endotoxins

        ≤0.01EU/U

        ≤0.01EU/IU

        Assay Anti- factor Xa activity

        90-125 IU/mg (on the dried basis)

        90-125 IU/mg (on the dried basis)

        Anti- factor IIa activity

        20.0-35.0 IU/mg (on the dried basis)

        20.0-35.0 IU/mg (on the dried basis)

        Indication

        1. Prevention of venous thromboembolic diseases (prevention of venous thrombosis), especially in relation to orthopaedic or general surgery

        2. Treatment of existing deep vein embolism, with or without pulmonary embolism, with mild clinical symptoms, excluding pulmonary embolism requiring surgery or thrombolytic therapy.

        3. Treatment of unstable angina pectoris and non-Q wave myocardial infarction, combined with aspirin.

        4. Used in cardiopulmonary bypass for hemodialysis to prevent thrombosis.


      2. Previous:
      3. Next:

      4. Write your message here and send it to us
        一级片在线免费观看_操逼91_97精品人妻人人做人人爽_久久久久久精品一区二区无码